IDH mut glioma stem-like NCH1681 cell line

Glioma stem-like cell line NCH1681 expressing mutant isocitrate dehydrogenase (IDH), used to model low-grade gliomas or secondary glioblastomas

Contributors

Inventor Institute
Christel Herold-Mende Heidelberg University
SKU: 162304
Product description: NCH1681 is a patient-derived glioma stem-like cell line carrying an IDH mutation, derived from the first relapse of an astrocytoma (WHO grade III). The tumour was obtained from a 38 year old female patient-derived during surgical resection. The primary tumour was reported as BRAF negative. Cells are cultured under serum-free conditions and grow as free floating neurospheres.
Production details: Patient-derived cell line established from human tumour tissue obtained during surgical resection and expanded in vitro.
Cat. #: 162304
Cancer types: Brain cancer
Organism: Human
Tissue: Brain
Morphology: Grown as free-floating neurospheres under serum-free culture conditions.
Growth properties: Cells grow as free-floating neurospheres under serum-free conditions in non-adherent culture vessels. Cultures are maintained at 37°C in a humidified incubator with 5% CO2.
Primary citation: Dettling et al. 2018. Clin Cancer Res. 24(12):2951-2962. PMID: 29563135.
Storage conditions: FCS-free freezing medium (Synth-a-freeze medium)
Growth medium: DMEM/F-12–based serum-free medium supplemented with BIT, GlutaMAX, EGF, and FGF-2.
Subculture routine: Neurospheres are passaged at high cell density by gentle mechanical dissociation. Accutase may be used if required to obtain single-cell suspensions. Cells are reseeded in fresh serum-free medium.
Temperature: 37°C
References:

Dettling et al. 2018. Clin Cancer Res. 24(12):2951-2962. PMID: 29563135.

Images

View Gallery
IDHmut glioma stem-like NCH1681 cell line

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.